CTXR - Citius Pharmaceuticals, Inc.

QQQ $ 435.69 $ 3.37 (0.78 %)

DIA $ 386.77 $ 0.03 (0.01 %)

SPY $ 511.68 $ 1.15 (0.23 %)

TLT $ 89.78 $ -0.33 (-0.37 %)

GLD $ 212.77 $ -0.67 (-0.31 %)

Previous Close

$ 0.707

Open

$ 0.70

Bid

$ 0.00 x 0

Ask

$ 4.40 x 100

Day's Range

$ 0.69 - $ 0.72

52 Week Range

$ 0.60 - $ 1.52

Volume

1,548,722

Average Volume

Market Cap

112.48M

Beta (5Y Monthly)

$ 0.70

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-14-2024	12-31-2023	10-Q
2	12-29-2023	09-30-2023	10-K
3	08-14-2023	06-30-2023	10-Q
4	05-12-2023	03-31-2023	10-Q
5	02-10-2023	12-31-2022	10-Q
6	12-22-2022	09-30-2022	10-K
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	02-10-2022	12-31-2021	10-Q
10	12-15-2021	09-30-2021	10-K
11	08-12-2021	06-30-2021	10-Q
12	05-13-2021	03-31-2021	10-Q
13	02-11-2021	12-31-2020	10-Q
14	12-16-2020	09-30-2020	10-K
15	08-14-2020	06-30-2020	10-Q
16	05-14-2020	03-31-2020	10-Q
17	02-13-2020	12-31-2019	10-Q
18	12-16-2019	09-30-2019	10-K
19	08-14-2019	06-30-2019	10-Q
20	05-15-2019	03-31-2019	10-Q
21	02-14-2019	12-31-2018	10-Q
22	12-11-2018	09-30-2018	10-K
23	08-14-2018	06-30-2018	10-Q
24	05-11-2018	03-31-2018	10-Q
25	02-14-2018	12-31-2017	10-Q
26	12-13-2017	09-30-2017	10-K
27	08-14-2017	06-30-2017	10-Q
28	05-15-2017	03-31-2017	10-Q
29	02-14-2017	12-31-2016	10-Q
30	12-23-2016	09-30-2016	10-K
31	08-15-2016	06-30-2016	10-Q
32	05-20-2016	03-31-2016	10-Q
33	02-12-2016	12-31-2015	10-Q
34	12-14-2015	09-30-2015	10-K
35	08-13-2015	06-30-2015	10-Q
36	05-13-2015	03-31-2015	10-Q
37	02-17-2015	12-31-2014	10-Q
38	08-14-2014	06-30-2014	10-Q
39	05-15-2014	03-31-2014	10-Q
40	02-19-2014	12-31-2013	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Citius Pharmaceuticals Announces $15M Regi...
04/26/2024 12:01:44

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
04/18/2024 12:09:32

University Of Minnesota Masonic Cancer Cen...
04/11/2024 12:40:47

National Cancer Institute (NCI)-designated research and treatment center City of Hope, in Duarte, CA, to participate in the Uni...

$citius-pharmaceuticals-announces-fda-acceptance-of-bla-resubmission-of-lymphir-for-treatment-of-adults-with-relapsed-or-refractory-cutaneous-t-cell-lymphoma$

Citius Pharmaceuticals Announces FDA Accep...
03/18/2024 12:37:38

FDA assigns Prescription Drug User Fee Act (PDUFA) target action date of August 13, 2024

Citius Pharmaceuticals Secures $2.4M Throu...
03/07/2024 13:35:41

Net operating losses converted into non-dilutive capital

Citius Pharma Q1 EPS $(0.06) Down From $(0...
02/14/2024 22:14:06

Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.06) per share. This is a 200 percent decrease over losses of $(0.0...

HC Wainwright & Co. Reiterates Buy on Citi...
02/14/2024 18:37:40

HC Wainwright & Co. analyst Vernon Bernardino reiterates Citius Pharma (NASDAQ:CTXR) with a Buy and maintains $4 price t...

Citius Pharmaceuticals Resubmits Biologics...
02/14/2024 13:09:55

Citius Pharmaceuticals Completes Enrollmen...
01/02/2024 13:37:12

Topline results expected 2Q 2024Study enrolled a total of 241 patients; 109 catheter failures observedFirst-and-only antibiotic...

Citius Pharmaceuticals FY23 EPS $(0.22) Vs...
01/02/2024 13:36:39

Net lossNet loss was $32.5 million, or ($0.22) per share for the year ended September 30, 2023, compared to a net loss of $33.6...

Citius Pharmaceuticals Announces Publicati...
10/31/2023 12:47:19

Preclinical study demonstrates that adding LYMPHIR to anti-PD-1 treatment augments anti-tumor activity and improves overall sur...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
10/24/2023 13:06:05

Citius Pharmaceuticals Executes Definitive...
10/24/2023 11:35:44

Upon closing, pursuant to the terms of the merger agreement, Citius Pharma would receive 67.5 million shares in Citius Oncolog...

Stocks That Hit 52-Week Lows On Tuesday
09/26/2023 16:04:06

On Tuesday, 386 stocks made new 52-week lows.

Citius Pharmaceuticals, Inc. Receives Regu...
09/08/2023 12:02:01

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ:CTXR) is pleased to announce the Company has r...

HC Wainwright & Co. Reiterates Buy on Citi...
08/10/2023 16:02:27

HC Wainwright & Co. analyst Vernon Bernardino reiterates Citius Pharma (NASDAQ:CTXR) with a Buy and maintains $4 price t...

Citius Pharmaceuticals Reaches 92 Event Mi...
08/10/2023 12:44:00

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ:CTXR), a late-stage biopharmaceutical company ...

HC Wainwright & Co. Maintains Buy on Citiu...
08/01/2023 11:22:22

HC Wainwright & Co. analyst Vernon Bernardino maintains Citius Pharma (NASDAQ:CTXR) with a Buy and lowers the price targ...

why-apellis-pharmaceuticals--shares-are-trading-lower-by-around-19-here-are-other-stocks-moving-in-mondays-session

Why Apellis Pharmaceuticals Shares Are Tr...
07/31/2023 19:30:12

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, acc...

why-citius-pharmaceuticals-stock-is-plunging-today

Why Citius Pharmaceuticals Stock Is Plungi...
07/31/2023 13:55:57

The FDA issued a Complete Response Letter regarding Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Biologics License Applicati...